Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents

The American Journal of Medicine

Volumn 84, Issue 2 SUPPL. 1, 1988, Pages 41-48

  Ivey, Kevin J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTI INFLAMMATORY AGENTS, NON STEROIDAL; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IATROGENIC DISEASE; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMAN;

EID: 0024294247     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(88)90253-7     Document Type: Article

References (54)

1. Effect of aspirin in the stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration
2. Time course, extent and duration of acute aspirin injury to the stomach of man
3. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effect of aspirin and paracetamol
4. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa
5. Comparison of the acute effects of regular aspirin, Bufferin, and paracetamol on human gastroduodenal mucosa
6. The effects of Motrin, Indocin, aspirin, Naprosyn and placebo on the gastric mucosa of normal volunteers, a gastroscopic study
7. The effects of Motrin, Indocin, aspirin, Naprosyn and placebo on the gastric mucosa of normal volunteers, a gastroscopic study and photographic study
8. Duodenal mucosal injury with non-steroidal anti-inflammatory drugs
9. Enteric coating of fenoprofen calcium reduces gastrointestinal microbleeding
10. The prevalence of duodenal lesions in patients with rheumatic disease on chronic aspirin therapy
11. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy
12. Acute hemorrhagic gastritis: modern concepts based on pathogenesis
13. Gastrointestinal haemorrhage and salicylates
14. The clinical spectrum of hemorrhagic erosive gastritis
15. Asymptomatic peptic ulcer disease
16. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration
17. Reduction of aspirin-induced gastrointestinal bleeding with cimetidine
18. Aspirin and gastrointestinal bleeding
19. Salicylates
20. Gastric mucosal barrier
21. Physiological parameters of the gastric mucosal barrier
22. Aspirin and the transmucosal potential difference
23. Aspirin-induced ultrastructural changes in human gastric mucosa
24. Effect of several drugs on gastric potential difference in man
25. Profile of gastric potential difference in man
26. Effect of non-steroidal anti-inflammatory drugs (NSAIDs) on rat gastric leukotriene formation
27. Reactive oxygen metabolites: mediators of cell injury in the digestive system
28. Protection of human gastric epithelial cells in vitro by the sulfhydryl agent cysteamine is not related to stimulation of prostaglandin synthesis
29. Effect of sodium bicarbonate on aspirin-induced damage and potential difference changes in human gastric mucosa
30. Aspirin injury to the gastric mucosa; gastric-camera observations of the effect of pH
31. 2 on aspirin-induced damage in rat gastric cultured cells
32. Comparison of the acute effects of regular aspirin, Bufferin and paracetamol on human gastroduodenal mucosa
33. Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat
34. Does sucralfate reduce acetyl salicylic-acid-induced gastric mucosal bleeding?
35. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats
36. Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands
37. Protection of human gastric epithelial cells in vitro by omeprazole: role of prostaglandin
38. Topical aspirin plus HCI gastric lesions in the rat
39. Cimetidine and omeprazole directly protect human gastric epithelial cells in vitro
40. Effect of cimetidine on indomethacin-induced damage in cultured rat gastric mucosal cells
41. Efficacy of anti-ulcer drugs on the recovery of gastric mucosal glycoproteins with aspirin-induced gastric damage in rat
42. Cimetidine induced bicarbonate production in canine gastric pouches
43. Effect of misoprolol and cimetidine on gastric cell labelling index
44. Effect of cimetidine on human gastric and duodenal prostanoid synthesis
45. 2 receptor blockers in the prevention of gastric injury resulting from nonsteroidal antiinflammatory agents
46. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine
47. Protective effect of cimetidine on aspirin-induced gastric mucosal damage
48. Damage and protection of the human gastric mucosa: a multiparameter assessment
49. Effect of cimetidine on indomethacin-related mucosal damage
50. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man
51. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin: a double-blind study with cimetidine and follow-up
52. Healing of aspirin associated peptic ulcer disease despite continued salicylate ingestion
53. The effect of cimetidine on peptic ulceration in patients receiving anti-inflammatory therapy
54. Randomized study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease